Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Immunological effects of HMG-CoA reductase inhibitors in humans

July 11, 1997

No Comments

Interleukin-11 reviewed

July 11, 1997

No Comments

FDA clears Bayer's cholesterol-lowering agent

July 10, 1997

No Comments

Exocell presents humanized MAb for diabetic nephropathy

July 10, 1997

No Comments

Novel hemoregulatory compounds from SKB

July 10, 1997

No Comments

Update on Pfizer/Ligand treatments for osteoporosis and breast cancer

July 9, 1997

No Comments

MGI Pharma launches INFeD for anemia in cancer patients

July 9, 1997

No Comments

Oxford GlycoSciences licenses compound for treatment of glycolipid storage disorders

July 9, 1997

No Comments

Didronel PMO now available for expanded use in the U.K.

July 9, 1997

No Comments

Lilly reports new salt of PKC inhibitor with improved pharmaceutical properties

July 9, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Endocrine/metabolic
RSS

Immunological effects of HMG-CoA reductase inhibitors in humans

Interleukin-11 reviewed

FDA clears Bayer's cholesterol-lowering agent

Exocell presents humanized MAb for diabetic nephropathy

Novel hemoregulatory compounds from SKB

Update on Pfizer/Ligand treatments for osteoporosis and breast cancer

MGI Pharma launches INFeD for anemia in cancer patients

Oxford GlycoSciences licenses compound for treatment of glycolipid storage disorders

Didronel PMO now available for expanded use in the U.K.

Lilly reports new salt of PKC inhibitor with improved pharmaceutical properties

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Endocrine/metabolic RSS

Endocrine/metabolic
RSS